Insulin Pump Tandem denied as not medically necessary by Cigna?

Cigna's specific coverage criteria for insulin pump tandem are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denies a Tandem Insulin Pump on Medical-Necessity Grounds

Cigna's medical-necessity review for insulin infusion pumps applies a structured clinical coverage policy with patient-selection criteria addressing diagnosis, current treatment regimen, glycemic control history, and patient capability to manage the device. A medical-necessity denial means Cigna's reviewer determined that the submitted documentation did not clearly satisfy one or more of those criteria — even when the prescriber and patient believe the device is clearly appropriate.

Common gaps that lead to this denial include: inadequate documentation of the current insulin regimen and its limitations, insufficient glycemic history in the chart, absence of a formal diabetes educator or endocrinology evaluation, or a prescriber letter that asserts necessity without mapping each policy criterion to a specific chart finding.

## Why This Denial Is Appealable

• Internal appeal (ACA §2719 / ERISA §503): You have the right to a full-and-fair internal review. Submit within the timeframe on the denial letter — typically 180 days for ERISA plans.
• External review: After the internal process, request independent external review under ACA §2719. The reviewer's decision is binding on Cigna. The external-review window is generally within four months of the final internal denial.
• Expedited review: Available when the patient's diabetes management is actively compromised and cannot wait for standard timelines.

## Documentation to Gather

1. Diagnosis confirmation: Chart documentation from an endocrinologist or qualified diabetes specialist confirming the diabetes type and current clinical status. 2. Current insulin regimen history: Detailed records of the patient's current multiple daily injection (MDI) or other insulin regimen — including start dates, any adjustments, and clinical outcomes. Cigna's policy typically requires documentation of an existing insulin regimen; confirm what the policy requires and ensure the records match. 3. Glycemic control history: Lab results and clinical notes documenting glycemic control over time, without citing specific numeric thresholds — the prescriber should frame this in terms of clinical adequacy or inadequacy relative to the patient's individualized treatment goals as documented in the chart. 4. Hypoglycemia documentation: Records of any significant hypoglycemic episodes, including dates and clinical context, as this is frequently a key criterion. 5. Prescriber medical-necessity letter: The ordering endocrinologist or diabetes specialist should write a letter that copies each of Cigna's coverage criteria and answers each one with a specific chart finding, date, and clinical observation. 6. Diabetes education: Documentation of diabetes self-management education, which Cigna's policy may require as a prerequisite.

## Criteria-Mapping Structure

Obtain Cigna's current published medical policy for insulin infusion pumps and the FDA-approved labeling for the Tandem device. Then map every criterion:

| Cigna Coverage Criterion | Supporting Chart Evidence | |---|---| | [Copy each criterion verbatim from the policy] | [Date, document type, and specific clinical finding] |